


Neovii
Biotechnology Research • Rapperswil, St Gallen, Switzerland • 101-200 Employees
Company overview
| Headquarters | Zürcherstrasse 19, Rapperswil, Sankt Gallen 8640, CH |
| Phone number | +41552100500 |
| Website | |
| SIC | 283 |
| Founded | 2003 |
| Employees | 101-200 |
| Socials |
Key Contact at Neovii
Neovii Email Formats
Neovii uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@neovii.com), used 54.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@neovii.com | 54.2% |
{first initial}.{last name} | j.doe@neovii.com | 45.8% |
About Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
Neovii revenue & valuation
| Annual revenue | $34,600,000 |
| Revenue per employee | $284,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $110,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Neovii has 57 employees across 12 departments.
Departments
Number of employees
Funding Data
Neovii has never raised funding before.
Neovii Tech Stack
Discover the technologies and tools that power Neovii's digital infrastructure, from frameworks to analytics platforms.
CDN
Analytics
JavaScript libraries
JavaScript libraries
JavaScript libraries
SSL/TLS certificate authorities
Web servers
Font scripts
JavaScript libraries
Webmail
Programming languages
Frequently asked questions
4.8
40,000 users



